Aardvark Therapeutics (AARD) Prepaid Assets (2024 - 2026)

Aardvark Therapeutics (AARD) reported Prepaid Assets of $2.4 million for Q1 2026, down 27.75% on a YoY basis from $3.3 million in Q1 2025, and up 28.03% sequentially from $1.9 million in Q4 2025.

Aardvark Therapeutics (AARD) Prepaid Assets (2024 - 2026) Analysis & Trends

Aardvark Therapeutics (AARD) has 3 years of Prepaid Assets data on file, last reported at $2.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets fell 27.75% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 27.75% YoY), and the FY2025 full-year result was $1.9 million, up 292.19% from the prior year.
  • Prepaid Assets improved to $2.4 million in Q1 2026, from $1.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.3 million in Q1 2025 to a low of $474000.0 in Q4 2024.
  • A 3-year average of $2.3 million and a median of $2.6 million in 2025 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets surged 292.19% in 2025 and decreased 27.75% in 2026, its largest moves.
  • Tracing AARD's Prepaid Assets over 3 years: stood at $474000.0 in 2024, then surged by 292.19% to $1.9 million in 2025, then increased by 28.03% to $2.4 million in 2026.
  • Business Quant data shows AARD's Prepaid Assets at $2.4 million in Q1 2026, $1.9 million in Q4 2025, and $2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Aardvark Therapeutics 139.40 Mn 19.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.38 Mn
Dec 31, 2025 1.86 Mn
Sep 30, 2025 2.86 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 3.29 Mn
Dec 31, 2024 474,000.00